Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New class of P2Y12 antagonists designed at Inspire as antithrombotics

July 12, 2002

SSR-182289: novel oral thrombin inhibitor with high potency and selectivity

July 10, 2002

Effective and safe new antithrombotic presented by Pfizer at IUPHAR 2002

July 10, 2002

Korean researchers report antithrombotic activity, mechanism of action of J-78 at IUPHAR 2002

July 9, 2002

Taiwan investigators report biological activity of new antiplatelet agent

July 9, 2002

Improvement in perfusion in rats with peripheral ischemia treated with 5-HT1B/5-HT2A antagonist

July 8, 2002

Takeda patent discloses novel factor Xa inhibitors

July 4, 2002

Alfimeprase enters phase I for peripheral arterial occlusion

July 4, 2002

CPMP recommends approval of new indication for clopidogrel

July 3, 2002

Baxter submits BLA for rAHF-PFM

July 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...